029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD1001膀胱肿瘤组织芯片,附TNM和临床分期,25例/100点
点 数100例 数25
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD1001
 
膀胱肿瘤组织微阵列芯片,包含25例尿路上皮癌,+每例四点,分成四个相同的小方阵(4x25点)
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
TISSUE  ARRAYS UBD1001
1
2
3
4
5
6
7
8
9
10
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
H
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
I
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
J
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A2267MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
A3351MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A4459FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A5558MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
A6672MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A7767MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
A8851MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A9959FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A101058MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
B11179FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
B21254MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant1*1*0.5N
B31345FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
B41470MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
B51556FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
B61679FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
B71754MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant1*1*0.5N
B81845FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
B91970MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
B102056FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
C12182FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
C22270FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant*N
C32365MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
C42478FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
C52570MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
C62682FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
C72770FBladderHigh grade urothelial carcinoma (sparse)*T3aM0N0IIIAMalignant*N
C82865MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
C92978FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
C103070MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
D13150FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D23248MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D33356MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
D43480MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
D53538MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
D63650FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D73748MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
D83856MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
D93980MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
D104038MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
E14173FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
E24267MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
E34371MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
E44445FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
E54561MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E64673FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
E74767MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
E84871MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
E94945FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
E105061MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
F15172MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
F25267MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
F35351MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
F45459FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
F55558MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
F65672MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
F75767MBladderLow-grade urothelial carcinoma*T2aN0M0IIMalignant3*1*0.5N
F85851MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
F95959FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
F106058MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
G16179FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
G26254MBladderLow-grade urothelial carcinoma (sparse)*T2N0M0IIMalignant1*1*0.5N
G36345FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
G46470MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
G56556FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
G66679FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
G76754MBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant1*1*0.5N
G86845FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
G96970MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
G107056FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant6*5*0.5N
H17182FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
H27270FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant*N
H37365MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
H47478FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
H57570MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
H67682FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
H77770FBladderHigh grade urothelial carcinoma*T3aM0N0IIIAMalignant*N
H87865MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
H97978FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
H108070MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
I18150FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
I28248MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
I38356MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
I48480MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
I58538MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
I68650FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
I78748MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
I88856MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
I98980MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
I109038MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
J19173FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
J29267MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
J39371MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
J49445FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
J59561MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
J69673FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
J79767MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant7*4*3N
J89871MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
J99945FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
J1010061MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情